<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="carasil" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">carasil</book-part-id>
      <title-group>
        <title>CARASIL</title>
        <alt-title alt-title-type="alt-title">Synonyms: Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, Maeda Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Onodera</surname>
            <given-names>Osamu</given-names>
          </name>
          <xref ref-type="aff" rid="carasil.AFF1"/>
          <degrees>MD, PhD</degrees>
          <email>onodera@bri.niigata-u.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Nozaki</surname>
            <given-names>Hiroaki</given-names>
          </name>
          <xref ref-type="aff" rid="carasil.AFF2"/>
          <degrees>MD, PhD</degrees>
          <email>nozak@bri.niigata-u.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Fukutake</surname>
            <given-names>Toshio</given-names>
          </name>
          <xref ref-type="aff" rid="carasil.AFF3"/>
          <degrees>MD, PhD</degrees>
          <email>tofuku@kameda.jp</email>
        </contrib>
      </contrib-group>
      <aff id="carasil.AFF1">Department of Molecular Neuroscience<break/>Resource Branch for Brain Disease<break/>Brain Research Institute<break/>Niigata University<break/>Niigata, Japan</aff>
      <aff id="carasil.AFF2">Department of Medical Technology<break/>School of Health Sciences Faculty of Medicine<break/>Niigata University<break/>Niigata, Japan</aff>
      <aff id="carasil.AFF3">Department of Neurology<break/>Kameda Medical Center<break/>Kamogawa, Japan</aff>
      <pub-history>
        <date iso-8601-date="2010-04-27" date-type="created">
          <day>27</day>
          <month>04</month>
          <year>2010</year>
        </date>
        <date iso-8601-date="2014-09-11" date-type="updated">
          <day>11</day>
          <month>09</month>
          <year>2014</year>
        </date>
        <date iso-8601-date="2011-02-17" date-type="revised">
          <day>17</day>
          <month>02</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="cadasil" document-type="chapter">CADASIL</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="cask-dis" document-type="chapter"><italic toggle="yes">CASK</italic>-Related Disorders</related-object>
      <abstract id="carasil.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>CARASIL (<italic toggle="yes">c</italic>erebral <italic toggle="yes">a</italic>utosomal <italic toggle="yes">r</italic>ecessive <italic toggle="yes">a</italic>rteriopathy with <italic toggle="yes">s</italic>ubcortical <italic toggle="yes">i</italic>nfarcts and <italic toggle="yes">l</italic>eukoencephalopathy) is characterized by early-onset changes in the deep white matter of the brain observed on MRI and associated neurologic findings. The most frequent initial symptom is gait disturbance from spasticity beginning between ages 20 and 30 years. Twenty-three percent of affected individuals have stroke-like episodes before age 40 years. Mood changes (apathy and irritability), pseudobulbar palsy, and cognitive dysfunction begin between ages 20 and 50 years. The disease progresses slowly over the five to 20 years following the onset of neurologic symptoms. Scalp alopecia before age 30 years and acute mid- to lower-back pain (lumbago) with onset between ages ten and 40 years are characteristic.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis relies on brain MRI findings and molecular genetic testing of <italic toggle="yes">HTRA1</italic>, the only gene in which pathogenic variants are known to be associated with CARASIL. </p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> supportive care including emotional support and counseling for affected individuals and their families; walking aids for gait disturbance and/or medication for spasticity; anxiolytic medication for character change as needed; routine care for dementia.</p>
          <p><italic toggle="yes">Surveillance:</italic> Follow-up intervals are based on the severity and type of symptoms and the needs of the individuals and their care givers.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>CARASIL is inherited in an autosomal recessive manner. Each sib of an affected individual has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for at-risk pregnancies is possible if the pathogenic variants in the family have been identified. </p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="carasil.Diagnosis">
        <title>Diagnosis</title>
        <sec id="carasil.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>CARASIL should be suspected in individuals <bold>presenting before age 55 years</bold> with:</p>
          <list list-type="bullet">
            <list-item>
              <p>Slowly progressive dementia</p>
              <list list-type="bullet">
                <list-item>
                  <p>Mood changes such as apathy and irritability</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Gait disturbance</p>
              <list list-type="bullet">
                <list-item>
                  <p>Spasticity (usually slowly progressive gait disturbance with spasticity in the lower extremities) [<xref ref-type="bibr" rid="carasil.REF.fukutake.1995.69">Fukutake &#x00026; Hirayama 1995</xref>, <xref ref-type="bibr" rid="carasil.REF.hara.2009.1729">Hara et al 2009</xref>, <xref ref-type="bibr" rid="carasil.REF.fukutake.2011.85">Fukutake 2011</xref>, <xref ref-type="bibr" rid="carasil.REF.nozaki.2014.1">Nozaki et al 2014</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Extended white matter lesions and external capsule lesions on brain imaging</p>
              <list list-type="bullet">
                <list-item>
                  <p>Early-onset leukoaraiosis (changes in deep white matter in the brain, observed on MRI or CT). Leukoaraiosis may precede neurologic symptoms [<xref ref-type="bibr" rid="carasil.REF.fukutake.1995.69">Fukutake &#x00026; Hirayama 1995</xref>, <xref ref-type="bibr" rid="carasil.REF.fukutake.2011.85">Fukutake 2011</xref>, <xref ref-type="bibr" rid="carasil.REF.nozaki.2014.1">Nozaki et al 2014</xref>].</p>
                </list-item>
                <list-item>
                  <p>Brain MRI resembling that of <related-object link-type="booklink" source-id="gene" document-id="cadasil" document-type="chapter">CADASIL</related-object> (<italic toggle="yes">c</italic>erebral <italic toggle="yes">a</italic>utosomal <italic toggle="yes">d</italic>ominant <italic toggle="yes">a</italic>rteriopathy with <italic toggle="yes">s</italic>ubcortical <italic toggle="yes">i</italic>nfarcts and <italic toggle="yes">l</italic>eukoencephalopathy). Findings in symptomatic individuals: </p>
                  <list list-type="bullet">
                    <list-item>
                      <p>White matter hyperintensities are symmetrically distributed and located in the periventricular and deep white matter [<xref ref-type="bibr" rid="carasil.REF.fukutake.1995.69">Fukutake &#x00026; Hirayama 1995</xref>, <xref ref-type="bibr" rid="carasil.REF.fukutake.2011.85">Fukutake 2011</xref>, <xref ref-type="bibr" rid="carasil.REF.nozaki.2014.1">Nozaki et al 2014</xref>], suggesting that the white matter changes precede the onset of neurologic symptoms, including gait disturbance, mood change, and cognitive decline.</p>
                    </list-item>
                    <list-item>
                      <p>T<sub>2</sub>-signal abnormalities in the white matter of the anterior part of the temporal lobe, the cerebellum, brain stem, middle cerebellar peduncle, and in the external capsule, characteristic of CARASIL, are sometimes observed [<xref ref-type="bibr" rid="carasil.REF.fukutake.2011.85">Fukutake 2011</xref>, <xref ref-type="bibr" rid="carasil.REF.nozaki.2014.1">Nozaki et al 2014</xref>].</p>
                    </list-item>
                    <list-item>
                      <p>Relative preservation of U-fibers is observed.</p>
                    </list-item>
                    <list-item>
                      <p>Lacunar infarcts (linearly arranged groups of rounded and circumscribed lesions with signal intensity identical to that of cerebrospinal fluid) are sometimes found in basal ganglia and subcortical white matter.</p>
                    </list-item>
                  </list>
                </list-item>
                <list-item>
                  <p>Note: The progression of MRI changes is not well documented in CARASIL; thus, it is not clear if the white matter changes in the anterior temporal poles and external capsule, which are characteristic signs in CADASIL, are also observed in early stages of CARASIL. </p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Additional young adult-onset findings: </p>
              <list list-type="bullet">
                <list-item>
                  <p>Spondylosis deformans. Acute mid- to lower-back pain (lumbago) associated with spondylosis and disk degeneration with osteophyte formation in the lumbar spine</p>
                </list-item>
                <list-item>
                  <p>Alopecia. Typically seen in teen yearsNote: Alopecia is variable: probands carrying <italic toggle="yes">HTRA1</italic> mutations without alopecia have been reported [<xref ref-type="bibr" rid="carasil.REF.yanagawa.2002.817">Yanagawa et al 2002</xref>, <xref ref-type="bibr" rid="carasil.REF.nishimoto.2011.1353">Nishimoto et al 2011</xref>, <xref ref-type="bibr" rid="carasil.REF.bianchi.2014.898">Bianchi et al 2014</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Family history consistent with autosomal recessive inheritance</p>
            </list-item>
          </list>
        </sec>
        <sec id="carasil.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of CARASIL is established in a proband with detection of biallelic pathogenic variants of <italic toggle="yes">HTRA1</italic> (<xref ref-type="table" rid="carasil.T.summary_of_molecular_genetic_t">Table 1</xref>). </p>
          <p>An alternative genetic testing strategy is use of a multi-gene panel that includes <italic toggle="yes">HTRA1</italic> and other genes of interest (see <xref ref-type="sec" rid="carasil.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time. </p>
          <table-wrap id="carasil.T.summary_of_molecular_genetic_t" position="anchor" orientation="portrait">
            <label>Table 1.</label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in CARASIL</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_carasil.T.summary_of_molecular_genetic_t_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_b_carasil.T.summary_of_molecular_genetic_t_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_b_carasil.T.summary_of_molecular_genetic_t_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
                <tr>
                  <td headers="hd_b_carasil.T.summary_of_molecular_genetic_t_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                    <italic toggle="yes">HTRA1</italic>
                  </td>
                  <td headers="hd_b_carasil.T.summary_of_molecular_genetic_t_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_b_carasil.T.summary_of_molecular_genetic_t_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Unknown&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_carasil.T.summary_of_molecular_genetic_t_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_carasil.T.summary_of_molecular_genetic_t_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Unknown</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="carasil.TF.1">
                <label>1.</label>
                <p>See <related-object source-id="gene" document-id="carasil" object-id="carasil.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="carasil.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene. </p>
              </fn>
              <fn id="carasil.TF.1.1">
                <label>2.</label>
                <p>Sequence analysis detects variants that are benign, likely benign, of unknown significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="carasil.TF.1.2">
                <label>3.</label>
                <p>
                  <xref ref-type="bibr" rid="carasil.REF.hara.2009.1729">Hara et al [2009]</xref>
                </p>
              </fn>
              <fn id="carasil.TF.1.3">
                <label>4.</label>
                <p>Testing that identifies exonic or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="carasil.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="carasil.Natural_History">
          <title>Clinical Description</title>
          <p><bold>Neurologic symptoms</bold> begin between ages 20 and 50 years. </p>
          <p>The most frequent initial symptom is slowly progressive gait disturbance from spasticity and pyramidal signs in the lower extremities beginning between ages 20 and 30 years. </p>
          <p>Mood change (depression and irritability) and cognitive dysfunction begin between ages 20 and 50 years. Pseudobulbar palsy also begins between ages 30 and 50 years. Twenty-three percent of affected individuals have a lacunar stroke-like episode (e.g., hemiparesis or hemisensory impairment) before age 40 years. </p>
          <p>The disease progresses slowly over five to 20 years following the onset of neurologic symptoms. In the advanced stage, emotional incontinence, abulia, and akinetic mutism develop. </p>
          <p><bold>Spondylosis</bold> (disk degeneration with osteophyte formation) results in acute lower- and mid-back pain (lumbago) and lower-limb pain beginning between ages ten and 30 years. MRI may show disc herniations, degeneration of vertebral bodies, and nodular thickening of the posterior longitudinal ligament [<xref ref-type="bibr" rid="carasil.REF.zheng.2009.847">Zheng et al 2009</xref>]. Also reported on radiography are severe spondylitis deformans with osteoporosis in the cervical and lumbar spine [<xref ref-type="bibr" rid="carasil.REF.nozaki.2014.1">Nozaki et al 2014</xref>] and deformity and formation of osseous specula in the knee joints [<xref ref-type="bibr" rid="carasil.REF.yanagawa.2002.817">Yanagawa et al 2002</xref>]. </p>
          <p><bold>Alopecia</bold> is frequently (not always) seen in the teen years. Scalp alopecia is diffuse, not confined to the frontal or parietal regions. There is no obvious body hair loss.</p>
          <p><bold>Pathology.</bold> From the autopsy findings, arteriosclerosis associated with intimal thickening and dense collagen fibers, loss of vascular smooth muscle cells, and hyaline degeneration of the media have been observed in cerebral small arteries. These pathologic findings resemble those observed in persons with non-hereditary ischemic cerebral small-vessel disease [<xref ref-type="bibr" rid="carasil.REF.maeda.1976.165">Maeda et al 1976</xref>, <xref ref-type="bibr" rid="carasil.REF.zhang.1997.219">Zhang &#x00026; Olsson 1997</xref>, <xref ref-type="bibr" rid="carasil.REF.tanoi.2000.347">Tanoi et al 2000</xref>, <xref ref-type="bibr" rid="carasil.REF.yanagawa.2002.817">Yanagawa et al 2002</xref>, <xref ref-type="bibr" rid="carasil.REF.okeda.2004.21">Okeda et al 2004</xref>, <xref ref-type="bibr" rid="carasil.REF.oide.2008.132">Oide et al 2008</xref>]. These changes are predominant in cerebral small arteries; therefore, skin biopsy is not useful for diagnosis. </p>
          <p>Note: Granular osmiophilic material within the vascular media close to smooth muscle cells, a pathologic hallmark for CADASIL, is never observed in CARASIL. </p>
        </sec>
        <sec id="carasil.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations </title>
          <p>No strong genotype-phenotype correlations exist in CARASIL. </p>
          <p>Individuals homozygous for the p.Arg370Ter pathogenic variant who make no protein as a result of nonsense-mediated mRNA decay cannot be clinically distinguished from individuals homozygous for the missense mutation who have some residual enzyme activity [<xref ref-type="bibr" rid="carasil.REF.hara.2009.1729">Hara et al 2009</xref>]. </p>
          <p>Siblings who share the same genotype may have a variable clinical course.</p>
        </sec>
        <sec id="carasil.Nomenclature">
          <title>Nomenclature </title>
          <p>Other names for CARASIL include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Familial young-adult-onset arteriosclerotic leukoencephalopathy with alopecia and lumbago without arterial hypertension</p>
            </list-item>
            <list-item>
              <p>Nemoto disease</p>
            </list-item>
          </list>
        </sec>
        <sec id="carasil.Prevalence">
          <title>Prevalence </title>
          <p>CARASIL has been reported in individuals from Japan, China, Spain, Turkey, and Italy. However, no founder haplotype has been identified; thus, the authors suspect that the disease will be found more widely. </p>
        </sec>
      </sec>
      <sec id="carasil.Genetically_Related_Allelic_Diso">
        <title>Genetically Related (Allelic) Disorders </title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">HTRA1</italic>.</p>
        <p>A SNP (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11200638">rs11200638</ext-link>: -512G&#x0003e;A) at the promoter region of <italic toggle="yes">HTRA1</italic> for which homozygosity for the AA genotype increased risk of wet age-related macular degeneration has been identified as age-related macular degeneration 7 (ARMD7) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/610149">610149</ext-link>). </p>
      </sec>
      <sec id="carasil.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Inherited disorders that cause leukoaraiosis in adulthood are summarized in <xref ref-type="table" rid="carasil.T.inherited_disorders_that_cause">Table 2</xref>. They can be distinguished from CARASIL by clinical signs, MRI findings, mode of inheritance, and appropriate laboratory investigations. </p>
        <table-wrap id="carasil.T.inherited_disorders_that_cause" position="anchor" orientation="portrait">
          <label>Table 2.</label>
          <caption>
            <p>Inherited Disorders that Cause Leukoaraiosis in Adulthood</p>
          </caption>
          <table>
            <tbody>
              <tr>
                <th id="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Disease</th>
                <th id="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Inheritance</th>
                <th id="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Gene</th>
                <th id="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unique Clinical Features</th>
                <th id="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">Selected OMIM Links</th>
              </tr>
              <tr>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="cadasil" document-type="chapter">CADASIL</related-object>&#x000a0;<sup>1</sup></td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">AD </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">
                  <italic toggle="yes">NOTCH3</italic>
                </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Isolated T<sub>2</sub> hyperintensities involving the temporal poles; skin biopsy can be evaluated for NOTCH3 protein expression and granular osmophilic material by EM </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>
                        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/125310">125310</ext-link>
                      </p>
                    </list-item>
                    <list-item>
                      <p>
                        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/600276">600276</ext-link>
                      </p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">HERNS (hereditary endotheliopathy with retinopathy, nephropathy, and stroke)&#x000a0;<sup>2</sup></td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">AD </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">TREX1</italic>
</td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Retinal artery abnormalities (macular capillary dropout, tortuous telangiectasia); progressive visual loss; Raynaud phenomenon, migraine, contrast-enhancing lesion, mimicking tumor; proteinuria and hematuria</td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>
                        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/192315">192315</ext-link>
                      </p>
                    </list-item>
                    <list-item>
                      <p>
                        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/606609">606609</ext-link>
                      </p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="col4a1-dis" document-type="chapter">HANAC (hereditary angiopathy with nephropathy, aneurysms and muscle cramps)</related-object>&#x000a0;<sup>3</sup></td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">AD </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">COL4A1</italic>
</td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Renal abnormalities (hematuria, cystic kidney), intracranial aneurysm, muscle cramps, retinal arteriolar tortuosity (retinal hemorrhages)</td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>
                        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/611773">611773</ext-link>
                      </p>
                    </list-item>
                    <list-item>
                      <p>
                        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/120130">120130</ext-link>
                      </p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="fabry" document-type="chapter">Fabry disease</related-object>
                </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">XR</td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">
                  <italic toggle="yes">GLA</italic>
                </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Periodic severe pain in the extremities, angiokeratoma, renal insufficiency, hypohidrosis, left ventricular hypertrophy, corneal opacities</td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>
                        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/301500">301500</ext-link>
                      </p>
                    </list-item>
                    <list-item>
                      <p>
                        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/600344">600344</ext-link>
                      </p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Familial cerebral amyloid angiopathy </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">AD </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">APP</italic>
</td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Lobar hemorrhage, multiple microbleeds</td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>
                        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/605714">605714</ext-link>
                      </p>
                    </list-item>
                    <list-item>
                      <p>
                        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/104760">104760</ext-link>
                      </p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Familial British dementia&#x000a0;<sup>4</sup></td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">AD </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">
                  <italic toggle="yes">ITM2B</italic>
                </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Ataxia and spasticity</td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>
                        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/176500">176500</ext-link>
                      </p>
                    </list-item>
                    <list-item>
                      <p>
                        <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/603904">603904</ext-link>
                      </p>
                    </list-item>
                  </list>
                </td>
              </tr>
              <tr>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Familial SVD, Portuguese-French type&#x000a0;<sup>5</sup></td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">AD </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Unknown </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"/>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">NA</td>
              </tr>
              <tr>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Swedish hereditary multi-infarct dementia&#x000a0;<sup>6</sup></td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">AD </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Unknown </td>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"/>
                <td headers="hd_b_carasil.T.inherited_disorders_that_cause_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">NA </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="carasil.TF.2">
              <p>NA = not available</p>
            </fn>
            <fn id="carasil.TF.2.1">
              <p>EM= electron microscopy</p>
            </fn>
            <fn id="carasil.TF.2.2">
              <p>SVD= small vessel disease </p>
            </fn>
            <fn id="carasil.TF.2.3">
              <p>1. <xref ref-type="bibr" rid="carasil.REF.chabriat.2009.643">Chabriat et al [2009]</xref></p>
            </fn>
            <fn id="carasil.TF.2.4">
              <p>2. <xref ref-type="bibr" rid="carasil.REF.jen.1997.1322">Jen et al [1997]</xref>, <xref ref-type="bibr" rid="carasil.REF.terwindt.1998.303">Terwindt et al [1998]</xref></p>
            </fn>
            <fn id="carasil.TF.2.5">
              <p>3. <xref ref-type="bibr" rid="carasil.REF.plaisier.2007.2687">Plaisier et al [2007]</xref></p>
            </fn>
            <fn id="carasil.TF.2.6">
              <p>4. <xref ref-type="bibr" rid="carasil.REF.mead.2000.975">Mead et al [2000]</xref></p>
            </fn>
            <fn id="carasil.TF.2.7">
              <p>5. <xref ref-type="bibr" rid="carasil.REF.verreault.2006.353">Verreault et al [2006]</xref></p>
            </fn>
            <fn id="carasil.TF.2.8">
              <p>6. <xref ref-type="bibr" rid="carasil.REF.low.2007.357">Low et al [2007]</xref></p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>The differential diagnosis of CARASIL comprises sporadic small vessel diseases including Binswanger disease, hereditary small vessel diseases (SVDs), and primary angiitis of the nervous system. The clinical characteristics and MRI abnormalities in these conditions may resemble those of CARASIL. Binswanger disease can be distinguished from CARASIL by the presence of hypertension. </p>
        <p>CARASIL should also be considered in any young person who has alopecia in conjunction with multiple white matter lesions on MRI.</p>
      </sec>
      <sec id="carasil.Management">
        <title>Management </title>
        <sec id="carasil.Evaluations_Following_Initial_Di">
          <title>Evaluations Following Initial Diagnosis </title>
          <p>To establish the extent of disease and needs in an individual diagnosed with CARASIL, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>T<sub>2</sub>* gradient echo imaging to check cerebral microbleeds</p>
            </list-item>
            <list-item>
              <p>Spine MRI to check the degenerative change in lumbar or cervical spine </p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="carasil.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Supportive care in the form of practical help, emotional support, and counseling are appropriate for affected individuals and their families. </p>
          <p>Gait disturbance from spasticity and pyramidal signs in the lower extremities may require walking aids or medication such as baclofen or tizanidine.</p>
          <p>Personality change may require antipsychotic medication.</p>
          <p>If spinal spondylosis is severe and patients show some neurologic deficit due to spinal compression, orthopedic treatment may be helpful to relieve symptoms.</p>
          <p>A wig or hairpiece may be helpful for alopecia.</p>
        </sec>
        <sec id="carasil.Prevention_of_Secondary_Complica">
          <title>Prevention of Secondary Complications</title>
          <p>Anti-platelet therapy and anti-hypertension therapy may be recommended; however, there is no evidence for their effectiveness.</p>
        </sec>
        <sec id="carasil.Surveillance">
          <title>Surveillance</title>
          <p>The interval at which a person with CARASIL are followed depends on the severity and type of symptoms and the needs of the affected individual and care givers.</p>
        </sec>
        <sec id="carasil.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Smoking and a high-salt diet, which may hasten the progression of arteriosclerosis, should be avoided. </p>
        </sec>
        <sec id="carasil.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It has been speculated that hypertension or smoking may influence the age of onset and frequency of stroke episodes in individuals with CARASIL; smoking may result in earlier disease onset [<xref ref-type="bibr" rid="carasil.REF.singhal.2004.2031">Singhal et al 2004</xref>] and smoking or hypertension may increase the frequency of stroke episodes in individuals with CADASIL [<xref ref-type="bibr" rid="carasil.REF.samii.2010.630">Samii et al 2010</xref>]. Therefore, it is appropriate to evaluate the older and younger sibs of a proband in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures such as oral administration of anti-hypertensive drugs and abstinence from smoking. </p>
          <list list-type="bullet">
            <list-item>
              <p>If the <italic toggle="yes">HTRA1</italic> pathogenic variants in the family are known, molecular genetic testing can be used to clarify the genetic status of at-risk sibs.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variants in the family are not known, brain MRI can be used to clarify the genetic status of at-risk sibs.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="carasil.Related_Genetic_Counseling_Issue">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
          <p><bold>Pregnancy Management</bold>
</p>
          <p>No special management is necessary in pregnancy for individual with CARASIL.</p>
        </sec>
        <sec id="carasil.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There is no clinical trial for this disorder. </p>
        </sec>
      </sec>
      <sec id="carasil.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="carasil.Mode_of_Inheritance">
          <title>Mode of Inheritance </title>
          <p>CARASIL is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="carasil.Risk_to_Family_Members">
          <title>Risk to Family Members </title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">HTRA1</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>It is not clear whether carriers are asymptomatic. Some reports suggest a mild phenotype in heterozygous individuals [<xref ref-type="bibr" rid="carasil.REF.mendioroz.2010.2033">Mendioroz et al 2010</xref>, <xref ref-type="bibr" rid="carasil.REF.chen.2013.1445">Chen et al 2013</xref>, <xref ref-type="bibr" rid="carasil.REF.bianchi.2014.898">Bianchi et al 2014</xref>]. However, it is difficult to distinguish their symptoms from the small vessel disease in elderly. Thus, further study is necessary to clarify this issue. </p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of being unaffected and not a carrier. </p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier of one <italic toggle="yes">HTRA1</italic> pathogenic variant is 2/3. </p>
            </list-item>
            <list-item>
              <p>It is not clear whether carriers are asymptomatic (see <bold>Parents of a proband</bold>, second bullet). </p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with CARASIL are obligate heterozygotes (carriers) for one <italic toggle="yes">HTRA1</italic> pathogenic variant. </p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier. </p>
        </sec>
        <sec id="carasil.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible if the pathogenic variants in the family have been identified. </p>
        </sec>
        <sec id="carasil.Related_Genetic_Counseling_Issue">
          <title>Related Genetic Counseling Issues </title>
          <p>See Management, <xref ref-type="sec" rid="carasil.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Testing of at-risk asymptomatic adult relatives</bold> of individuals with CARASIL is possible after molecular genetic testing has identified the specific pathogenic variants in the family. Such testing should be performed in the context of formal genetic counseling, and is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing. </p>
          <p><bold>Testing of asymptomatic individuals younger than age 18 years</bold> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause. </p>
          <p>Testing is always appropriate to consider in symptomatic individuals in a family with an established diagnosis of CARASIL regardless of age. </p>
          <p>For more information, see also the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being affected or of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="carasil.Prenatal_Testing">
          <title>Prenatal Testing </title>
          <p>If the <italic toggle="yes">HTRA1</italic> pathogenic variants have been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this gene or custom prenatal testing.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the <italic toggle="yes">HTRA1</italic> pathogenic variants have been identified. </p>
        </sec>
      </sec>
      <sec id="carasil.Resources">
        <title>Resources</title>
      </sec>
      <sec id="carasil.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">HTRA1</italic> has nine exons and a transcript 2138 bp in length. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="carasil" object-id="carasil.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> Six missense mutations in exons 3 and 4, two nonsense mutations, and one deletion have been reported. See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="PDF File" xlink:href="carasil-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf).</p>
        <p><bold>Normal gene product.</bold> HTRA1, a 480-amino acid protein, belongs to the HTRA protein family, the members of which have dual roles as chaperones and serine proteases [<xref ref-type="bibr" rid="carasil.REF.clausen.2002.443">Clausen et al 2002</xref>]. Members of the HTRA family serve as stress sensors for unfolded proteins and repress transforming growth factor-beta (TGF-&#x003b2;) family signaling [<xref ref-type="bibr" rid="carasil.REF.clausen.2002.443">Clausen et al 2002</xref>, <xref ref-type="bibr" rid="carasil.REF.oka.2004.1041">Oka et al 2004</xref>]. HTRA1 is a serine protease; its protease domain is encoded in exons 3-6 [<xref ref-type="bibr" rid="carasil.REF.hara.2009.1729">Hara et al 2009</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Biochemical and functional studies of mutant HTRA1 with CARASIL revealed the loss of protease activity and consequent dysinhibition of TGF-&#x003b2; family signaling of mutant HTRA1 [<xref ref-type="bibr" rid="carasil.REF.hara.2009.1729">Hara et al 2009</xref>]. </p>
      </sec>
      <sec id="carasil.References">
        <title>References</title>
        <sec id="carasil.Published_GuidelinesConsensus_St">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="carasil.Published_GuidelinesConsensus_St.reflist0">
            <ref id="carasil.REF.americansocietyofhuma.1995.1">
              <mixed-citation publication-type="book">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 2-18-15.</mixed-citation>
            </ref>
            <ref id="carasil.REF.nationalsocietyofgene.2012.1">
              <mixed-citation publication-type="book">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 9-8-14.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="carasil.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="carasil.Literature_Cited.reflist0">
            <ref id="carasil.REF.bianchi.2014.898">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bianchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Palma</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallus</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taglia</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poggiani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rufa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muresanu</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerase</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Two novel HTRA1 mutations in a European CARASIL patient.</article-title>
                <source>Neurology.</source>
                <year>2014</year>
                <volume>82</volume>
                <fpage>898</fpage>
                <lpage>900</lpage>
                <pub-id pub-id-type="pmid">24500651</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.chabriat.2009.643">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chabriat</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joutel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <article-title>Cadasil.</article-title>
                <source>Lancet Neurol.</source>
                <year>2009</year>
                <volume>8</volume>
                <fpage>643</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">19539236</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.chen.2013.1445">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meng</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X.</given-names>
                  </name>
                </person-group>
                <article-title>A novel mutation of the high-temperature requirement A serine peptidase 1 (HTRA1) gene in a Chinese family with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL).</article-title>
                <source>J Int Med Res.</source>
                <year>2013</year>
                <volume>41</volume>
                <fpage>1445</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">23963851</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.clausen.2002.443">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clausen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Southan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ehrmann</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>The HtrA family of proteases: implications for protein composition and cell fate.</article-title>
                <source>Mol Cell.</source>
                <year>2002</year>
                <volume>10</volume>
                <fpage>443</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">12408815</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.fukutake.2011.85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fukutake</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): From discovery to gene identification.</article-title>
                <source>J Stroke Cerebrovasc Dis.</source>
                <year>2011</year>
                <volume>20</volume>
                <fpage>85</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">21215656</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.fukutake.1995.69">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fukutake</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirayama</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Familial young-adult-onset arteriosclerotic leukoencephalopathy with alopecia and lumbago without arterial hypertension.</article-title>
                <source>Eur Neurol</source>
                <year>1995</year>
                <volume>35</volume>
                <fpage>69</fpage>
                <lpage>79</lpage>
                <pub-id pub-id-type="pmid">7796840</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.hara.2009.1729">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukutake</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nozaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyashita</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoseki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawata</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koyama</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiota</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimoe</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirayama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arisato</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanagawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeuchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuwano</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <article-title>Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease.</article-title>
                <source>N Engl J Med.</source>
                <year>2009</year>
                <volume>360</volume>
                <fpage>1729</fpage>
                <lpage>39</lpage>
                <pub-id pub-id-type="pmid">19387015</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.jen.1997.1322">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stout</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vinters</surname>
                    <given-names>HV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <article-title>Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS).</article-title>
                <source>Neurology.</source>
                <year>1997</year>
                <volume>49</volume>
                <fpage>1322</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">9371916</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.low.2007.357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Low</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Junna</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borjesson-Hanson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St Clair</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuno</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mykkanen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wahlstrom</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersen</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalimo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viitanen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalaria</surname>
                    <given-names>RN</given-names>
                  </name>
                </person-group>
                <article-title>Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL.</article-title>
                <source>Brain.</source>
                <year>2007</year>
                <volume>130</volume>
                <fpage>357</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">17235124</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.maeda.1976.165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maeda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakayama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aihara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemoto</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Familial unusual encephalopathy of Binswanger's type without hypertension.</article-title>
                <source>Folia Psychiatr Neurol Jpn.</source>
                <year>1976</year>
                <volume>30</volume>
                <fpage>165</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">971885</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.mead.2000.975">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mead</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>James-Galton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Revesz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doshi</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harwood</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pan</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghiso</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frangione</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plant</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings.</article-title>
                <source>Brain.</source>
                <year>2000</year>
                <volume>123</volume>
                <fpage>975</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">10775542</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.mendioroz.2010.2033">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mendioroz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez-Cadenas</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del R&#x000ed;o-Espinola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rovira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sol&#x000e9;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez-Figueras</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Patos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sastre-Garriga</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domingues-Montanari</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvarez-Sab&#x000ed;n</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montaner</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian population.</article-title>
                <source>Neurology.</source>
                <year>2010</year>
                <volume>75</volume>
                <fpage>2033</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21115960</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.nishimoto.2011.1353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nishimoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nihonmatsu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nozaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shirata</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamane</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosakai</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>N.</given-names>
                  </name>
                </person-group>
                <article-title>A novel mutation in the HTRA1 gene causes CARASIL without alopecia.</article-title>
                <source>Neurology.</source>
                <year>2011</year>
                <volume>76</volume>
                <fpage>1353</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21482952</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.nozaki.2014.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nozaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O.</given-names>
                  </name>
                </person-group>
                <article-title>Features of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy.</article-title>
                <source>Stroke.</source>
                <year>2014</year>
                <pub-id pub-id-type="pmid">25116877</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.oide.2008.132">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oide</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakayama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanagawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arima</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Extensive loss of arterial medial smooth muscle cells and mural extracellular matrix in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL).</article-title>
                <source>Neuropathology.</source>
                <year>2008</year>
                <volume>28</volume>
                <fpage>132</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">18021191</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.oka.2004.1041">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oka</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsujimoto</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kajikawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koshiba-Takeuchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ina</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuchiya</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueta</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soma</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanda</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawaichi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins.</article-title>
                <source>Development.</source>
                <year>2004</year>
                <volume>131</volume>
                <fpage>1041</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">14973287</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.okeda.2004.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Okeda</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawabe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuroiwa</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Pathology of the cerebral artery in Binswanger's disease in the aged: observation by serial sections and morphometry of the cerebral arteries.</article-title>
                <source>Neuropathology.</source>
                <year>2004</year>
                <volume>24</volume>
                <fpage>21</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15068169</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.plaisier.2007.2687">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Plaisier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gribouval</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alamowitch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mougenot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prost</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verpont</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marro</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desmettre</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roullet</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dracon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Agtmael</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerjaschki</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antignac</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronco</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.</article-title>
                <source>N Engl J Med.</source>
                <year>2007</year>
                <volume>357</volume>
                <fpage>2687</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">18160688</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.samii.2010.630">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Samii</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markus</surname>
                    <given-names>HS</given-names>
                  </name>
                </person-group>
                <article-title>Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals.</article-title>
                <source>Stroke</source>
                <year>2010</year>
                <volume>41</volume>
                <fpage>630</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20167921</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.singhal.2004.2031">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Singhal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bevan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrick</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rich</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markus</surname>
                    <given-names>HS</given-names>
                  </name>
                </person-group>
                <article-title>The influence of genetic and cardiovascular risk factors on the CADASIL phenotype.</article-title>
                <source>Brain.</source>
                <year>2004</year>
                <volume>127</volume>
                <fpage>2031</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15229130</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.tanoi.2000.347">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tanoi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okeda</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Budka</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Binswanger's encephalopathy: serial sections and morphometry of the cerebral arteries.</article-title>
                <source>Acta Neuropathol.</source>
                <year>2000</year>
                <volume>100</volume>
                <fpage>347</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">10985691</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.terwindt.1998.303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ophoff</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groenen</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Storimans</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanser</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bleeker-Wagemakers</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon.</article-title>
                <source>Brain.</source>
                <year>1998</year>
                <volume>121</volume>
                <fpage>303</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">9549508</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.verreault.2006.353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verreault</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joutel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riant</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neves</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rui Silva</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maciazek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabriat</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>A novel hereditary small vessel disease of the brain.</article-title>
                <source>Ann Neurol.</source>
                <year>2006</year>
                <volume>59</volume>
                <fpage>353</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16404745</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.yanagawa.2002.817">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yanagawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy.</article-title>
                <source>Neurology.</source>
                <year>2002</year>
                <volume>58</volume>
                <fpage>817</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">11889251</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.zhang.1997.219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsson</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>The angiopathy of subcortical arteriosclerotic encephalopathy (Binswanger's disease): immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells.</article-title>
                <source>Acta Neuropathol.</source>
                <year>1997</year>
                <volume>93</volume>
                <fpage>219</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">9083552</pub-id>
              </element-citation>
            </ref>
            <ref id="carasil.REF.zheng.2009.847">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zheng</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>FF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bi</surname>
                    <given-names>GR</given-names>
                  </name>
                </person-group>
                <article-title>A Chinese pedigree of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): Clinical and radiological features.</article-title>
                <source>J Clin Neurosci.</source>
                <year>2009</year>
                <volume>16</volume>
                <fpage>847</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19299137</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="carasil.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="carasil.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>11 September 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>17 February 2011 (cd) Revision: prenatal testing available clinically</p>
            </list-item>
            <list-item>
              <p>27 April 2010 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>5 January 2010 (oo) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
